Suppr超能文献

围手术期因素对接受肝切除术的肝细胞癌患者预后的影响。

Effect of perioperative factors on the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy.

机构信息

Department of General Surgery, The Second Medical Center - National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.

Department of Internal Medicine, Henan Cancer Hospital, Zhengzhou, China.

出版信息

Turk J Med Sci. 2022 Aug;52(4):1067-1074. doi: 10.55730/1300-0144.5409. Epub 2022 Aug 10.

Abstract

BACKGROUND

Hepatic resection is a potentially curative treatment for patients with hepatocellular carcinoma (HCC). Controversy persists regarding preoperative and intraoperative characteristics related to patient survival in various medical institutes. This study aimed to evaluate the impact of preoperative and intraoperative factors on the long-term survival of patients with HCC who underwent hepatectomy.

METHODS

Data on 455 patients with HCC who underwent hepatectomy over a 20-year period were retrospectively reviewed. Univariate and multivariate Cox regression analyses were performed for preoperative- and intraoperative-related prognostic factors.

RESULTS

The 1-, 3-, 5-, and 10-year overall survival rates of patients with HCC who underwent resection were 76.3%, 57.9%, 46.7%, and 27.4%, respectively. Multivariate analyses identified four independent predictors of long-term prognosis-sex (male versus female, hazard ratio [HR] = 2.732, p = 0.026); differentiation (poor versus well, HR = 2.037, p = 0.030); total bilirubin value (μmol/L, HR = 1.056, p = 0.033); and intraoperative blood transfusion (no transfusion versus transfusion, HR = 0.417, p = 0.002). Hepatitis virus B infection (negative versus positive, HR = 0.669, p = 0.232) and resection style (anatomical versus nonanatomical, HR = 0.698, p = 0.181) were not associated with survival.

DISCUSSION

Based on this 20-year study, poor survival of patients with HCC who underwent hepatectomy was correlated with preoperative and intraoperative factors including male sex, poor differentiation, increased total bilirubin levels, and intraoperative blood transfusion.

摘要

背景

肝切除术是治疗肝细胞癌(HCC)患者的一种潜在治愈性治疗方法。在不同的医疗机构中,关于与患者生存相关的术前和术中特征仍然存在争议。本研究旨在评估术前和术中因素对接受肝切除术的 HCC 患者长期生存的影响。

方法

回顾性分析了 20 年来接受肝切除术的 455 例 HCC 患者的数据。对术前和术中相关预后因素进行单因素和多因素 Cox 回归分析。

结果

接受切除术的 HCC 患者的 1、3、5 和 10 年总生存率分别为 76.3%、57.9%、46.7%和 27.4%。多因素分析确定了四个独立的长期预后预测因素-性别(男性与女性,风险比[HR] = 2.732,p = 0.026);分化(差与好,HR = 2.037,p = 0.030);总胆红素值(μmol/L,HR = 1.056,p = 0.033);术中输血(无输血与输血,HR = 0.417,p = 0.002)。乙型肝炎病毒感染(阴性与阳性,HR = 0.669,p = 0.232)和切除方式(解剖与非解剖,HR = 0.698,p = 0.181)与生存无关。

讨论

基于这项 20 年的研究,接受肝切除术的 HCC 患者的生存率较差与术前和术中因素相关,包括男性、低分化、总胆红素水平升高和术中输血。

相似文献

1
Effect of perioperative factors on the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy.
Turk J Med Sci. 2022 Aug;52(4):1067-1074. doi: 10.55730/1300-0144.5409. Epub 2022 Aug 10.
2
Perioperative factors related to the prognosis of elderly patients with hepatocellular carcinoma.
Eur J Med Res. 2022 Dec 9;27(1):280. doi: 10.1186/s40001-022-00896-5.
4
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
5
[Surgical treatment of primary liver cancer:a report of 10 966 cases].
Zhonghua Wai Ke Za Zhi. 2021 Jan 1;59(1):6-17. doi: 10.3760/cma.j.cn112139-20201110-00791.
6
Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma.
World J Gastroenterol. 2012 Jul 7;18(25):3272-81. doi: 10.3748/wjg.v18.i25.3272.
10
Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):178-85. doi: 10.1016/s1499-3872(15)60353-8.

引用本文的文献

1
A systematic review and meta-analysis of blood transfusion rates during liver resection by country.
Ann Surg Treat Res. 2023 Dec;105(6):404-416. doi: 10.4174/astr.2023.105.6.404. Epub 2023 Nov 29.

本文引用的文献

3
Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis.
Int J Surg. 2020 Aug;80:243-255. doi: 10.1016/j.ijsu.2020.05.008. Epub 2020 May 13.
4
Epidemiology of Hepatocellular Carcinoma.
Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):4-13. doi: 10.1002/hep.31288. Epub 2020 Nov 24.
6
Burden of liver diseases in the world.
J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26.
7
Risk assessment for liver resection.
Surgery. 2018 Nov;164(5):998-1005. doi: 10.1016/j.surg.2018.06.024. Epub 2018 Aug 12.
8
Liver resection for hepatocellular carcinoma: personal experiences in a series of 1330 consecutive cases in China.
ANZ J Surg. 2018 Oct;88(10):E713-E717. doi: 10.1111/ans.14381. Epub 2018 Jan 23.
9
Preoperative optimization for major hepatic resection.
Langenbecks Arch Surg. 2018 Feb;403(1):23-35. doi: 10.1007/s00423-017-1638-x. Epub 2017 Nov 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验